Kiio study highlights how an exercise therapy app can help employers and payers reduce costs associated with low back and other joint pain

MedCity News August 25, 2021
Stephanie Baum

Among the large, claims-based study’s findings was a dramatic 62% lower medical spend, 89% lower opioid use, and 51% lower use of antidepressants for Kiio participants.

Musculoskeletal (MSK) pain is one of the most common maladies, affecting bones, joints, ligaments, tendons or muscles in areas like the back and hips. It also can be a big part of employers’ medical bills. One in two adults have a MSK issue every year, and these disorders cost an estimated $213 billion annually in treatment, care, and lost wages.

Recognizing the opportunity to use innovation to combat this problem, Kiio developed a digital MSK therapy solution that combines advanced software and evidenced-based guidelines to treat and prevent back, knee, neck, and hip...

Today's Sponsors

Today's Sponsor